Intersect ENT

Results: 36



#Item
21Intersect ENT Announces Appointment of Cynthia L. Lucchese to Board of Directors Menlo Park, Calif. – July 11, 2014 – Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life

Intersect ENT Announces Appointment of Cynthia L. Lucchese to Board of Directors Menlo Park, Calif. – July 11, 2014 – Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life

Add to Reading List

Source URL: propelopens.com

Language: English - Date: 2014-07-11 15:43:46
    22Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors MENLO PARK, Calif., April 9, [removed]Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with

    Intersect ENT Appoints Kieran Gallahue and Tony Vernon to Board of Directors MENLO PARK, Calif., April 9, [removed]Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2015-04-09 20:24:03
    23Media Contact: Nicole Osmer[removed]removed] Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes For Sinus Surgery

    Media Contact: Nicole Osmer[removed]removed] Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes For Sinus Surgery

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-04-17 10:11:17
    24Intersect ENT to Present at the 32nd Annual J.P. Morgan Healthcare Conference Menlo Park, Calif. – Jan. 8, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their

    Intersect ENT to Present at the 32nd Annual J.P. Morgan Healthcare Conference Menlo Park, Calif. – Jan. 8, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and their

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-04-17 10:12:02
    25Intersect ENT Announces Enrollment of First Patient In Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis Menlo Park, Calif. – Dec. 29, 2014 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicate

    Intersect ENT Announces Enrollment of First Patient In Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis Menlo Park, Calif. – Dec. 29, 2014 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicate

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-12-29 18:58:43
    26Intersect ENT Appoints Chas McKhann as Chief Commercial Officer Menlo Park, Calif. – February 2, 2015––Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear,

    Intersect ENT Appoints Chas McKhann as Chief Commercial Officer Menlo Park, Calif. – February 2, 2015––Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear,

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2015-02-03 12:17:27
    27Intersect ENT Added To Russell 2000 Index Menlo Park, Calif. – Oct. 1, 2014 – Intersect ENT (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today

    Intersect ENT Added To Russell 2000 Index Menlo Park, Calif. – Oct. 1, 2014 – Intersect ENT (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-10-01 16:51:05
    28Intersect ENT Named One of the “Fierce 15” Most Promising Private Companies by FierceMedicalDevices Menlo Park, Calif. – Oct. 15, 2013 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and

    Intersect ENT Named One of the “Fierce 15” Most Promising Private Companies by FierceMedicalDevices Menlo Park, Calif. – Oct. 15, 2013 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-04-17 10:11:02
    29Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients RESOLVE Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Post-Sinus Surgery Patients wi

    Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients RESOLVE Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Post-Sinus Surgery Patients wi

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-04-17 10:11:35
    30Intersect ENT Named One of Forbes Magazine’s “America’s Most Promising Companies” of 2014 Menlo Park, Calif. – Jan. 23, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat

    Intersect ENT Named One of Forbes Magazine’s “America’s Most Promising Companies” of 2014 Menlo Park, Calif. – Jan. 23, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat

    Add to Reading List

    Source URL: propelopens.com

    Language: English - Date: 2014-04-17 10:11:37